nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2C9—Capecitabine—esophageal cancer	0.149	0.665	CbGbCtD
Sulfadiazine—CYP2C9—Cisplatin—esophageal cancer	0.075	0.335	CbGbCtD
Sulfadiazine—Diuresis—Cisplatin—esophageal cancer	0.0185	0.0633	CcSEcCtD
Sulfadiazine—Skin necrosis—Cisplatin—esophageal cancer	0.0164	0.0562	CcSEcCtD
Sulfadiazine—Necrolysis epidermal—Methotrexate—esophageal cancer	0.0139	0.0474	CcSEcCtD
Sulfadiazine—Reaction gastrointestinal—Methotrexate—esophageal cancer	0.00944	0.0323	CcSEcCtD
Sulfadiazine—Skin necrosis—Methotrexate—esophageal cancer	0.00902	0.0308	CcSEcCtD
Sulfadiazine—Anuria—Methotrexate—esophageal cancer	0.00902	0.0308	CcSEcCtD
Sulfadiazine—Sulfathiazole—CYP19A1—esophageal cancer	0.0082	0.248	CrCbGaD
Sulfadiazine—Body temperature increased—Carboplatin—esophageal cancer	0.00552	0.0189	CcSEcCtD
Sulfadiazine—Skin exfoliation—Cisplatin—esophageal cancer	0.00548	0.0187	CcSEcCtD
Sulfadiazine—Eruption—Methotrexate—esophageal cancer	0.00512	0.0175	CcSEcCtD
Sulfadiazine—Polyuria—Cisplatin—esophageal cancer	0.00475	0.0162	CcSEcCtD
Sulfadiazine—Skin discolouration—Capecitabine—esophageal cancer	0.00469	0.016	CcSEcCtD
Sulfadiazine—Haemolytic anaemia—Cisplatin—esophageal cancer	0.00462	0.0158	CcSEcCtD
Sulfadiazine—Burning sensation—Methotrexate—esophageal cancer	0.00453	0.0155	CcSEcCtD
Sulfadiazine—Sulfanilamide—CA2—esophageal cancer	0.00448	0.136	CrCbGaD
Sulfadiazine—Sulfasalazine—ABCC2—esophageal cancer	0.00447	0.135	CrCbGaD
Sulfadiazine—Sulfaphenazole—CYP2A6—esophageal cancer	0.00433	0.131	CrCbGaD
Sulfadiazine—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00431	0.0147	CcSEcCtD
Sulfadiazine—Skin exfoliation—Capecitabine—esophageal cancer	0.00404	0.0138	CcSEcCtD
Sulfadiazine—Sepsis—Capecitabine—esophageal cancer	0.00367	0.0126	CcSEcCtD
Sulfadiazine—Pancreatitis—Cisplatin—esophageal cancer	0.00353	0.0121	CcSEcCtD
Sulfadiazine—Polyuria—Capecitabine—esophageal cancer	0.0035	0.012	CcSEcCtD
Sulfadiazine—Skin discolouration—Methotrexate—esophageal cancer	0.00349	0.0119	CcSEcCtD
Sulfadiazine—Vascular purpura—Capecitabine—esophageal cancer	0.00343	0.0117	CcSEcCtD
Sulfadiazine—Oliguria—Methotrexate—esophageal cancer	0.00342	0.0117	CcSEcCtD
Sulfadiazine—Haemolytic anaemia—Capecitabine—esophageal cancer	0.0034	0.0116	CcSEcCtD
Sulfadiazine—Sulfasalazine—PTGS1—esophageal cancer	0.00339	0.102	CrCbGaD
Sulfadiazine—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.00326	0.0111	CcSEcCtD
Sulfadiazine—Purpura—Capecitabine—esophageal cancer	0.00319	0.0109	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00315	0.0108	CcSEcCtD
Sulfadiazine—Stomatitis—Cisplatin—esophageal cancer	0.00313	0.0107	CcSEcCtD
Sulfadiazine—Skin exfoliation—Methotrexate—esophageal cancer	0.00301	0.0103	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Methotrexate—esophageal cancer	0.00296	0.0101	CcSEcCtD
Sulfadiazine—Ataxia—Capecitabine—esophageal cancer	0.00289	0.00988	CcSEcCtD
Sulfadiazine—Sulfamethoxazole—PTGS1—esophageal cancer	0.00281	0.0849	CrCbGaD
Sulfadiazine—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.00277	0.00946	CcSEcCtD
Sulfadiazine—Sepsis—Methotrexate—esophageal cancer	0.00273	0.00935	CcSEcCtD
Sulfadiazine—Tinnitus—Cisplatin—esophageal cancer	0.00269	0.00919	CcSEcCtD
Sulfadiazine—Polyuria—Methotrexate—esophageal cancer	0.0026	0.0089	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.00242	0.00829	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00236	0.00808	CcSEcCtD
Sulfadiazine—Depression—Capecitabine—esophageal cancer	0.00236	0.00807	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00235	0.00802	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00232	0.00793	CcSEcCtD
Sulfadiazine—Stomatitis—Capecitabine—esophageal cancer	0.00231	0.00789	CcSEcCtD
Sulfadiazine—Leukopenia—Cisplatin—esophageal cancer	0.00225	0.00768	CcSEcCtD
Sulfadiazine—Agranulocytosis—Capecitabine—esophageal cancer	0.00221	0.00755	CcSEcCtD
Sulfadiazine—Dapsone—PTGS1—esophageal cancer	0.0022	0.0664	CrCbGaD
Sulfadiazine—Convulsion—Cisplatin—esophageal cancer	0.00217	0.00743	CcSEcCtD
Sulfadiazine—Ataxia—Methotrexate—esophageal cancer	0.00215	0.00735	CcSEcCtD
Sulfadiazine—Hepatitis—Capecitabine—esophageal cancer	0.00213	0.00727	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.00206	0.00704	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Cisplatin—esophageal cancer	0.00205	0.007	CcSEcCtD
Sulfadiazine—Erythema multiforme—Capecitabine—esophageal cancer	0.00201	0.00687	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Cisplatin—esophageal cancer	0.00201	0.00686	CcSEcCtD
Sulfadiazine—Tinnitus—Capecitabine—esophageal cancer	0.00198	0.00677	CcSEcCtD
Sulfadiazine—Anorexia—Cisplatin—esophageal cancer	0.00195	0.00668	CcSEcCtD
Sulfadiazine—Pancreatitis—Methotrexate—esophageal cancer	0.00194	0.00663	CcSEcCtD
Sulfadiazine—Sulfasalazine—PTGS2—esophageal cancer	0.00194	0.0586	CrCbGaD
Sulfadiazine—Chills—Capecitabine—esophageal cancer	0.00191	0.00652	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00187	0.00638	CcSEcCtD
Sulfadiazine—Decreased appetite—Cisplatin—esophageal cancer	0.00178	0.00609	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00177	0.00605	CcSEcCtD
Sulfadiazine—Depression—Methotrexate—esophageal cancer	0.00176	0.00601	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00175	0.00597	CcSEcCtD
Sulfadiazine—Stomatitis—Methotrexate—esophageal cancer	0.00172	0.00587	CcSEcCtD
Sulfadiazine—Vertigo—Capecitabine—esophageal cancer	0.00166	0.00568	CcSEcCtD
Sulfadiazine—Leukopenia—Capecitabine—esophageal cancer	0.00166	0.00566	CcSEcCtD
Sulfadiazine—Agranulocytosis—Methotrexate—esophageal cancer	0.00164	0.00562	CcSEcCtD
Sulfadiazine—Body temperature increased—Cisplatin—esophageal cancer	0.00162	0.00554	CcSEcCtD
Sulfadiazine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00158	0.00352	CbGpPWpGaD
Sulfadiazine—Hepatitis—Methotrexate—esophageal cancer	0.00158	0.00541	CcSEcCtD
Sulfadiazine—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00158	0.0035	CbGpPWpGaD
Sulfadiazine—Arthralgia—Capecitabine—esophageal cancer	0.00158	0.00539	CcSEcCtD
Sulfadiazine—CYP2C8—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00156	0.00347	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00151	0.00335	CbGpPWpGaD
Sulfadiazine—Hypersensitivity—Cisplatin—esophageal cancer	0.00151	0.00516	CcSEcCtD
Sulfadiazine—Erythema multiforme—Methotrexate—esophageal cancer	0.0015	0.00511	CcSEcCtD
Sulfadiazine—CYP2C9—Arachidonic acid metabolism—CYP1B1—esophageal cancer	0.00149	0.00331	CbGpPWpGaD
Sulfadiazine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00149	0.00331	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00149	0.0033	CbGpPWpGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00148	0.00329	CbGpPWpGaD
Sulfadiazine—Thrombocytopenia—Capecitabine—esophageal cancer	0.00148	0.00505	CcSEcCtD
Sulfadiazine—CYP2E1—Biological oxidations—ADH1B—esophageal cancer	0.00148	0.00328	CbGpPWpGaD
Sulfadiazine—Tinnitus—Methotrexate—esophageal cancer	0.00148	0.00504	CcSEcCtD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00147	0.00327	CbGpPWpGaD
Sulfadiazine—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.00147	0.00326	CbGpPWpGaD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00146	0.00324	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—ADH7—esophageal cancer	0.00146	0.00323	CbGpPWpGaD
Sulfadiazine—Anorexia—Capecitabine—esophageal cancer	0.00144	0.00492	CcSEcCtD
Sulfadiazine—Chills—Methotrexate—esophageal cancer	0.00142	0.00485	CcSEcCtD
Sulfadiazine—Diarrhoea—Cisplatin—esophageal cancer	0.0014	0.00479	CcSEcCtD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.0014	0.0031	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.00139	0.00308	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00138	0.00306	CbGpPWpGaD
Sulfadiazine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00138	0.0047	CcSEcCtD
Sulfadiazine—CYP2E1—Biological oxidations—CYP26A1—esophageal cancer	0.00137	0.00305	CbGpPWpGaD
Sulfadiazine—Insomnia—Capecitabine—esophageal cancer	0.00137	0.00467	CcSEcCtD
Sulfadiazine—CYP2E1—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00136	0.00301	CbGpPWpGaD
Sulfadiazine—Decreased appetite—Capecitabine—esophageal cancer	0.00131	0.00449	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.0013	0.00446	CcSEcCtD
Sulfadiazine—Vomiting—Cisplatin—esophageal cancer	0.0013	0.00445	CcSEcCtD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.0013	0.00288	CbGpPWpGaD
Sulfadiazine—Rash—Cisplatin—esophageal cancer	0.00129	0.00442	CcSEcCtD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00129	0.00287	CbGpPWpGaD
Sulfadiazine—Dermatitis—Cisplatin—esophageal cancer	0.00129	0.00441	CcSEcCtD
Sulfadiazine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00129	0.00286	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00128	0.00285	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—ADH1B—esophageal cancer	0.00128	0.00284	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—GSTO1—esophageal cancer	0.00128	0.00284	CbGpPWpGaD
Sulfadiazine—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00127	0.00282	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—GSTO1—esophageal cancer	0.00126	0.0028	CbGpPWpGaD
Sulfadiazine—Dapsone—PTGS2—esophageal cancer	0.00125	0.038	CrCbGaD
Sulfadiazine—Vertigo—Methotrexate—esophageal cancer	0.00124	0.00423	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00123	0.00422	CcSEcCtD
Sulfadiazine—Leukopenia—Methotrexate—esophageal cancer	0.00123	0.00421	CcSEcCtD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00123	0.00273	CbGpPWpGaD
Sulfadiazine—Nausea—Cisplatin—esophageal cancer	0.00122	0.00416	CcSEcCtD
Sulfadiazine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00121	0.00269	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00121	0.00268	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.0012	0.00266	CbGpPWpGaD
Sulfadiazine—Urticaria—Capecitabine—esophageal cancer	0.0012	0.0041	CcSEcCtD
Sulfadiazine—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.0012	0.00266	CbGpPWpGaD
Sulfadiazine—Abdominal pain—Capecitabine—esophageal cancer	0.00119	0.00408	CcSEcCtD
Sulfadiazine—Body temperature increased—Capecitabine—esophageal cancer	0.00119	0.00408	CcSEcCtD
Sulfadiazine—Convulsion—Methotrexate—esophageal cancer	0.00119	0.00408	CcSEcCtD
Sulfadiazine—CYP2C8—Biological oxidations—CYP26A1—esophageal cancer	0.00119	0.00264	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—ADH7—esophageal cancer	0.00119	0.00263	CbGpPWpGaD
Sulfadiazine—Arthralgia—Methotrexate—esophageal cancer	0.00117	0.00401	CcSEcCtD
Sulfadiazine—CYP2C8—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00117	0.0026	CbGpPWpGaD
Sulfadiazine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.00116	0.00257	CbGpPWpGaD
Sulfadiazine—Anaphylactic shock—Methotrexate—esophageal cancer	0.00112	0.00384	CcSEcCtD
Sulfadiazine—Hypersensitivity—Capecitabine—esophageal cancer	0.00111	0.0038	CcSEcCtD
Sulfadiazine—CYP2C8—Biological oxidations—GSTO1—esophageal cancer	0.0011	0.00245	CbGpPWpGaD
Sulfadiazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.0011	0.00245	CbGpPWpGaD
Sulfadiazine—Thrombocytopenia—Methotrexate—esophageal cancer	0.0011	0.00376	CcSEcCtD
Sulfadiazine—CYP2C8—Metapathway biotransformation—GSTO1—esophageal cancer	0.00109	0.00242	CbGpPWpGaD
Sulfadiazine—Anorexia—Methotrexate—esophageal cancer	0.00107	0.00366	CcSEcCtD
Sulfadiazine—Pruritus—Capecitabine—esophageal cancer	0.00107	0.00365	CcSEcCtD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00105	0.00234	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.00105	0.00233	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00105	0.00232	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—ALDH2—esophageal cancer	0.00104	0.00231	CbGpPWpGaD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00104	0.00231	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—ADH1B—esophageal cancer	0.00104	0.00231	CbGpPWpGaD
Sulfadiazine—Diarrhoea—Capecitabine—esophageal cancer	0.00103	0.00353	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00102	0.0035	CcSEcCtD
Sulfadiazine—Insomnia—Methotrexate—esophageal cancer	0.00102	0.00348	CcSEcCtD
Sulfadiazine—CYP2E1—Biological oxidations—GSTT1—esophageal cancer	0.00099	0.0022	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000989	0.0022	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000983	0.00218	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—CYP2A6—esophageal cancer	0.000979	0.00217	CbGpPWpGaD
Sulfadiazine—Decreased appetite—Methotrexate—esophageal cancer	0.000977	0.00334	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00097	0.00332	CcSEcCtD
Sulfadiazine—CYP2C9—Biological oxidations—CYP26A1—esophageal cancer	0.000967	0.00215	CbGpPWpGaD
Sulfadiazine—Vomiting—Capecitabine—esophageal cancer	0.00096	0.00328	CcSEcCtD
Sulfadiazine—CYP2C9—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000953	0.00212	CbGpPWpGaD
Sulfadiazine—Rash—Capecitabine—esophageal cancer	0.000952	0.00325	CcSEcCtD
Sulfadiazine—Dermatitis—Capecitabine—esophageal cancer	0.000951	0.00325	CcSEcCtD
Sulfadiazine—Headache—Capecitabine—esophageal cancer	0.000946	0.00323	CcSEcCtD
Sulfadiazine—CYP2E1—Biological oxidations—PTGS1—esophageal cancer	0.000928	0.00206	CbGpPWpGaD
Sulfadiazine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000919	0.00314	CcSEcCtD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00091	0.00202	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—ALDH2—esophageal cancer	0.0009	0.002	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GSTO1—esophageal cancer	0.000899	0.002	CbGpPWpGaD
Sulfadiazine—Nausea—Capecitabine—esophageal cancer	0.000897	0.00307	CcSEcCtD
Sulfadiazine—Urticaria—Methotrexate—esophageal cancer	0.000893	0.00305	CcSEcCtD
Sulfadiazine—Body temperature increased—Methotrexate—esophageal cancer	0.000889	0.00304	CcSEcCtD
Sulfadiazine—Abdominal pain—Methotrexate—esophageal cancer	0.000889	0.00304	CcSEcCtD
Sulfadiazine—CYP2C9—Metapathway biotransformation—GSTO1—esophageal cancer	0.000886	0.00197	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—GSTT1—esophageal cancer	0.000856	0.0019	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000855	0.0019	CbGpPWpGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00085	0.00189	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—CYP2A6—esophageal cancer	0.000846	0.00188	CbGpPWpGaD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000839	0.00186	CbGpPWpGaD
Sulfadiazine—Hypersensitivity—Methotrexate—esophageal cancer	0.000828	0.00283	CcSEcCtD
Sulfadiazine—CYP2C8—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000826	0.00183	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000811	0.0018	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—PTGS1—esophageal cancer	0.000802	0.00178	CbGpPWpGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000799	0.00177	CbGpPWpGaD
Sulfadiazine—Pruritus—Methotrexate—esophageal cancer	0.000795	0.00272	CcSEcCtD
Sulfadiazine—CYP2E1—Biological oxidations—CYP1B1—esophageal cancer	0.000789	0.00175	CbGpPWpGaD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000789	0.00175	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000782	0.00174	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000778	0.00173	CbGpPWpGaD
Sulfadiazine—Diarrhoea—Methotrexate—esophageal cancer	0.000769	0.00263	CcSEcCtD
Sulfadiazine—CYP2E1—Biological oxidations—CYP19A1—esophageal cancer	0.000742	0.00165	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—ALDH2—esophageal cancer	0.000733	0.00163	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000732	0.00162	CbGpPWpGaD
Sulfadiazine—Vomiting—Methotrexate—esophageal cancer	0.000715	0.00244	CcSEcCtD
Sulfadiazine—Rash—Methotrexate—esophageal cancer	0.000709	0.00242	CcSEcCtD
Sulfadiazine—Dermatitis—Methotrexate—esophageal cancer	0.000708	0.00242	CcSEcCtD
Sulfadiazine—Headache—Methotrexate—esophageal cancer	0.000704	0.00241	CcSEcCtD
Sulfadiazine—CYP2C9—Biological oxidations—GSTT1—esophageal cancer	0.000697	0.00155	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000689	0.00153	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—CYP2A6—esophageal cancer	0.000689	0.00153	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000686	0.00152	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—CYP1B1—esophageal cancer	0.000682	0.00151	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000673	0.00149	CbGpPWpGaD
Sulfadiazine—CYP2C9—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000672	0.00149	CbGpPWpGaD
Sulfadiazine—Nausea—Methotrexate—esophageal cancer	0.000668	0.00228	CcSEcCtD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000658	0.00146	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—PTGS1—esophageal cancer	0.000653	0.00145	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000648	0.00144	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—CYP19A1—esophageal cancer	0.000641	0.00142	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000637	0.00142	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000633	0.0014	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000629	0.0014	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000593	0.00132	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000585	0.0013	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—CYP1B1—esophageal cancer	0.000555	0.00123	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000548	0.00122	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000536	0.00119	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	0.000522	0.00116	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000515	0.00114	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000483	0.00107	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.00046	0.00102	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000454	0.00101	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000444	0.000987	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000431	0.000956	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—BLVRB—esophageal cancer	0.000399	0.000885	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SLC52A3—esophageal cancer	0.000399	0.000885	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000388	0.000861	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000366	0.000813	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000362	0.000803	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000361	0.000802	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SLC52A3—esophageal cancer	0.000345	0.000765	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—BLVRB—esophageal cancer	0.000345	0.000765	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000344	0.000764	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00034	0.000754	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CA1—esophageal cancer	0.000339	0.000753	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SLC10A2—esophageal cancer	0.000339	0.000753	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000316	0.000701	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CA2—esophageal cancer	0.00031	0.000688	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000308	0.000684	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SLC10A2—esophageal cancer	0.000293	0.000651	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CA1—esophageal cancer	0.000293	0.000651	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PLCE1—esophageal cancer	0.000288	0.00064	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ADH7—esophageal cancer	0.000288	0.00064	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—BLVRB—esophageal cancer	0.00028	0.000623	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SLC52A3—esophageal cancer	0.00028	0.000623	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CA2—esophageal cancer	0.000268	0.000595	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000262	0.000582	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ADH1B—esophageal cancer	0.000253	0.000561	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000251	0.000557	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PLCE1—esophageal cancer	0.000249	0.000553	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ADH7—esophageal cancer	0.000249	0.000553	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000246	0.000547	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—TYMP—esophageal cancer	0.000242	0.000536	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SLC10A2—esophageal cancer	0.000238	0.000529	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CA1—esophageal cancer	0.000238	0.000529	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP26A1—esophageal cancer	0.000235	0.000522	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ALOX15—esophageal cancer	0.000229	0.000508	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ADH1B—esophageal cancer	0.000218	0.000485	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTO1—esophageal cancer	0.000218	0.000485	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—TPI1—esophageal cancer	0.000218	0.000485	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CA2—esophageal cancer	0.000218	0.000484	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000213	0.000473	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ALDOB—esophageal cancer	0.000209	0.000465	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—TYMP—esophageal cancer	0.000209	0.000464	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP26A1—esophageal cancer	0.000203	0.000451	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PLCE1—esophageal cancer	0.000203	0.00045	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ADH7—esophageal cancer	0.000203	0.00045	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GAPDH—esophageal cancer	0.000202	0.000448	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.0002	0.000445	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CRABP1—esophageal cancer	0.0002	0.000444	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ALOX15—esophageal cancer	0.000198	0.000439	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GNG7—esophageal cancer	0.00019	0.000422	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—TPI1—esophageal cancer	0.000189	0.000419	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTO1—esophageal cancer	0.000189	0.000419	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000185	0.000411	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000185	0.000411	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ALDOB—esophageal cancer	0.000181	0.000402	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ALDH2—esophageal cancer	0.000178	0.000395	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ADH1B—esophageal cancer	0.000178	0.000395	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GAPDH—esophageal cancer	0.000174	0.000387	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CRABP1—esophageal cancer	0.000173	0.000383	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—TYMP—esophageal cancer	0.00017	0.000377	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTT1—esophageal cancer	0.000169	0.000376	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP2A6—esophageal cancer	0.000167	0.000372	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP26A1—esophageal cancer	0.000165	0.000367	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GNG7—esophageal cancer	0.000164	0.000365	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ALOX15—esophageal cancer	0.000161	0.000358	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PTGS1—esophageal cancer	0.000159	0.000352	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ENO1—esophageal cancer	0.000159	0.000352	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CA1—esophageal cancer	0.000157	0.000349	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000157	0.000349	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PSME2—esophageal cancer	0.000156	0.000347	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PSME1—esophageal cancer	0.000156	0.000347	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ALDH2—esophageal cancer	0.000154	0.000342	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—TPI1—esophageal cancer	0.000154	0.000341	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTO1—esophageal cancer	0.000154	0.000341	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ALDOB—esophageal cancer	0.000147	0.000327	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTT1—esophageal cancer	0.000146	0.000325	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP2A6—esophageal cancer	0.000145	0.000321	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000144	0.00032	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CA2—esophageal cancer	0.000144	0.000319	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GAPDH—esophageal cancer	0.000142	0.000315	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CRABP1—esophageal cancer	0.000141	0.000312	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PTGS1—esophageal cancer	0.000137	0.000305	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ENO1—esophageal cancer	0.000137	0.000305	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PSME2—esophageal cancer	0.000135	0.0003	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PSME1—esophageal cancer	0.000135	0.0003	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP1B1—esophageal cancer	0.000135	0.0003	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PLCE1—esophageal cancer	0.000134	0.000297	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ADH7—esophageal cancer	0.000134	0.000297	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GNG7—esophageal cancer	0.000134	0.000297	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP19A1—esophageal cancer	0.000127	0.000282	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ALDH2—esophageal cancer	0.000125	0.000278	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTT1—esophageal cancer	0.000119	0.000265	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000118	0.000262	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP2A6—esophageal cancer	0.000118	0.000261	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000117	0.00026	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ADH1B—esophageal cancer	0.000117	0.00026	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP1B1—esophageal cancer	0.000117	0.000259	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—HMOX1—esophageal cancer	0.000116	0.000257	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—TYMP—esophageal cancer	0.000112	0.000249	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ENO1—esophageal cancer	0.000112	0.000248	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PTGS1—esophageal cancer	0.000112	0.000248	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ABCB1—esophageal cancer	0.000111	0.000247	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PSME1—esophageal cancer	0.00011	0.000244	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PSME2—esophageal cancer	0.00011	0.000244	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP19A1—esophageal cancer	0.00011	0.000244	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	0.000109	0.000242	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALOX15—esophageal cancer	0.000106	0.000236	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—TPI1—esophageal cancer	0.000101	0.000225	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTO1—esophageal cancer	0.000101	0.000225	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HMOX1—esophageal cancer	0.0001	0.000222	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.82e-05	0.000218	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALDOB—esophageal cancer	9.72e-05	0.000216	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	9.61e-05	0.000213	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ABCB1—esophageal cancer	9.61e-05	0.000213	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP1B1—esophageal cancer	9.49e-05	0.000211	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GAPDH—esophageal cancer	9.35e-05	0.000208	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CRABP1—esophageal cancer	9.27e-05	0.000206	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP19A1—esophageal cancer	8.93e-05	0.000198	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GNG7—esophageal cancer	8.82e-05	0.000196	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALDH2—esophageal cancer	8.26e-05	0.000183	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HMOX1—esophageal cancer	8.15e-05	0.000181	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.99e-05	0.000177	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTT1—esophageal cancer	7.86e-05	0.000174	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ABCB1—esophageal cancer	7.82e-05	0.000174	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	7.77e-05	0.000172	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CREBBP—esophageal cancer	7.43e-05	0.000165	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ENO1—esophageal cancer	7.36e-05	0.000163	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PTGS1—esophageal cancer	7.36e-05	0.000163	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.26e-05	0.000161	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PSME1—esophageal cancer	7.26e-05	0.000161	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PSME2—esophageal cancer	7.26e-05	0.000161	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NOS3—esophageal cancer	6.65e-05	0.000148	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CREBBP—esophageal cancer	6.42e-05	0.000143	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	6.26e-05	0.000139	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PTGS2—esophageal cancer	6.08e-05	0.000135	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.91e-05	0.000131	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	5.89e-05	0.000131	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NOS3—esophageal cancer	5.75e-05	0.000128	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HMOX1—esophageal cancer	5.37e-05	0.000119	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PTGS2—esophageal cancer	5.26e-05	0.000117	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CREBBP—esophageal cancer	5.23e-05	0.000116	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ABCB1—esophageal cancer	5.16e-05	0.000114	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—EP300—esophageal cancer	5.06e-05	0.000112	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NOS3—esophageal cancer	4.68e-05	0.000104	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—EP300—esophageal cancer	4.37e-05	9.71e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PTGS2—esophageal cancer	4.28e-05	9.5e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CA—esophageal cancer	3.74e-05	8.31e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—EP300—esophageal cancer	3.56e-05	7.9e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.45e-05	7.65e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CA—esophageal cancer	3.23e-05	7.18e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NOS3—esophageal cancer	3.09e-05	6.85e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.82e-05	6.27e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	2.63e-05	5.84e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—EP300—esophageal cancer	2.35e-05	5.21e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.74e-05	3.85e-05	CbGpPWpGaD
